These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 24259417)

  • 1. ALX/FPR2 receptor for RvD1 is expressed and functional in salivary glands.
    Nelson JW; Leigh NJ; Mellas RE; McCall AD; Aguirre A; Baker OJ
    Am J Physiol Cell Physiol; 2014 Jan; 306(2):C178-85. PubMed ID: 24259417
    [TBL] [Abstract][Full Text] [Related]  

  • 2. AT-RvD1 combined with DEX is highly effective in treating TNF-α-mediated disruption of the salivary gland epithelium.
    Easley JT; Maruyama CL; Wang CS; Baker OJ
    Physiol Rep; 2016 Oct; 4(19):. PubMed ID: 27694530
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Resolvin D1 prevents TNF-α-mediated disruption of salivary epithelial formation.
    Odusanwo O; Chinthamani S; McCall A; Duffey ME; Baker OJ
    Am J Physiol Cell Physiol; 2012 May; 302(9):C1331-45. PubMed ID: 22237406
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of resolvin D1 biosynthetic pathways in salivary epithelium.
    Leigh NJ; Nelson JW; Mellas RE; Aguirre A; Baker OJ
    J Dent Res; 2014 Mar; 93(3):300-5. PubMed ID: 24389810
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Specialized pro-resolving receptors are expressed in salivary glands with Sjögren's syndrome.
    Dos Santos HT; Nam K; Maslow F; Trump B; Baker OJ
    Ann Diagn Pathol; 2022 Feb; 56():151865. PubMed ID: 34847389
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sex-mediated elevation of the specialized pro-resolving lipid mediator levels in a Sjögren's syndrome mouse model.
    Parashar K; Schulte F; Hardt M; Baker OJ
    FASEB J; 2020 Jun; 34(6):7733-7744. PubMed ID: 32277856
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Resolvin D1 receptor stereoselectivity and regulation of inflammation and proresolving microRNAs.
    Krishnamoorthy S; Recchiuti A; Chiang N; Fredman G; Serhan CN
    Am J Pathol; 2012 May; 180(5):2018-27. PubMed ID: 22449948
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The G-Protein-Coupled Receptor ALX/Fpr2 Regulates Adaptive Immune Responses in Mouse Submandibular Glands.
    Wang CS; Baker OJ
    Am J Pathol; 2018 Jul; 188(7):1555-1562. PubMed ID: 29684359
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Functions of resolvin D1-ALX/FPR2 receptor interaction in the hemoglobin-induced microglial inflammatory response and neuronal injury.
    Liu GJ; Tao T; Wang H; Zhou Y; Gao X; Gao YY; Hang CH; Li W
    J Neuroinflammation; 2020 Aug; 17(1):239. PubMed ID: 32795323
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ALX/FPR2 Modulates Anti-Inflammatory Responses in Mouse Submandibular Gland.
    Wang CS; Wee Y; Yang CH; Melvin JE; Baker OJ
    Sci Rep; 2016 Apr; 6():24244. PubMed ID: 27064029
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ALX/FPR2 Activation by Stereoisomers of D1 Resolvins Elucidating with Molecular Dynamics Simulation.
    Nunes VS; Abrahão O; Rogério AP; Serhan CN
    J Phys Chem B; 2023 Jul; 127(29):6479-6486. PubMed ID: 37428488
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aspirin Triggered Resolvin D1 reduces inflammation and restores saliva secretion in a Sjögren's syndrome mouse model.
    Dean S; Wang CS; Nam K; Maruyama CL; Trump BG; Baker OJ
    Rheumatology (Oxford); 2019 Jul; 58(7):1285-1292. PubMed ID: 30877775
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Insights into the Activation Mechanism of the ALX/FPR2 Receptor.
    Schmitz Nunes V; Rogério AP; Abrahão O
    J Phys Chem Lett; 2020 Nov; 11(21):8952-8957. PubMed ID: 33030905
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aspirin-Triggered Resolvin D1 Versus Dexamethasone in the Treatment of Sjögren's Syndrome-Like NOD/ShiLtJ Mice - A Pilot Study.
    Easley JT; Nelson JW; Mellas RE; Sommakia S; Wu C; Trump B; Baker OJ
    J Rheum Dis Treat; 2015; 1(4):. PubMed ID: 27110599
    [TBL] [Abstract][Full Text] [Related]  

  • 15. AT-RvD1 Promotes Resolution of Inflammation in NOD/ShiLtJ mice.
    Wang CS; Maruyama CL; Easley JT; Trump BG; Baker OJ
    Sci Rep; 2017 Mar; 7():45525. PubMed ID: 28361884
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Resolvin D1 protects the liver from ischemia/reperfusion injury by enhancing M2 macrophage polarization and efferocytosis.
    Kang JW; Lee SM
    Biochim Biophys Acta; 2016 Sep; 1861(9 Pt A):1025-1035. PubMed ID: 27317426
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Resolvin D1 limits polymorphonuclear leukocyte recruitment to inflammatory loci: receptor-dependent actions.
    Norling LV; Dalli J; Flower RJ; Serhan CN; Perretti M
    Arterioscler Thromb Vasc Biol; 2012 Aug; 32(8):1970-8. PubMed ID: 22499990
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Myeloid ALX/FPR2 regulates vascularization following tissue injury.
    Sansbury BE; Li X; Wong B; Patsalos A; Giannakis N; Zhang MJ; Nagy L; Spite M
    Proc Natl Acad Sci U S A; 2020 Jun; 117(25):14354-14364. PubMed ID: 32513697
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Heterologously expressed formyl peptide receptor 2 (FPR2/ALX) does not respond to lipoxin A₄.
    Hanson J; Ferreirós N; Pirotte B; Geisslinger G; Offermanns S
    Biochem Pharmacol; 2013 Jun; 85(12):1795-802. PubMed ID: 23643932
    [TBL] [Abstract][Full Text] [Related]  

  • 20. VIP protects human retinal microvascular endothelial cells against high glucose-induced increases in TNF-α and enhances RvD1.
    Shi H; Carion TW; Jiang Y; Steinle JJ; Berger EA
    Prostaglandins Other Lipid Mediat; 2016 Mar; 123():28-32. PubMed ID: 27026343
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.